Mohamed Fares

发表

Ameliorative and protective effects of ginger and its main constituents against natural, chemical and radiation-induced toxicities: A comprehensive review.

Muhammad A. Alsherbiny, Wessam H. Abd-elsalam, S. A. El Badawy, 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.

C. Supuran, Mohamed Fares, H. Abdel‐Aziz, 2016, European journal of medicinal chemistry.

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer*

Bernard Schneider, Niels Lion, Patrick Aebischer, 2012, The Journal of Biological Chemistry.

Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides

Mohamed Fares, H. Abdel‐Aziz, Wagdy M. Eldehna, 2015, Molecules.

N-terminal phosphorylation of Huntingtin: A molecular switch for regulating Htt aggregation, helical conformation, internalization and nuclear targeting

H. Lashuel, A. Chiki, Mohamed Fares, 2018, bioRxiv.

Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.

Tamer M. Ibrahim, F. Boeckler, Mohamed Fares, 2019, European journal of medicinal chemistry.

A patent review of anticancer CDK2 inhibitors (2017–present)

Mohamed A. Abdelrahman, Mohamed Fares, Wagdy M. Eldehna, 2022, Expert opinion on therapeutic patents.

Mechanistic insights to the cardioprotective effect of blueberry nutraceutical extract in isoprenaline-induced cardiac hypertrophy.

Mohamed Fares, Wesam M. El-Bakly, Eman M. Mantawy, 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Incidence of Human Cytomegalovirus in Breast Carcinoma Tissues is Associated with A Higher Expression of Growth Factor Receptor-Bound Protein 2

Mohamed Fares, H. Mohamed, M. El-Shinawi, 2019, The Egyptian Journal of Hospital Medicine.

Development of Potent Nanosized Isatin-isonicotinohydrazide Hybrid for Management of Mycobacterium Tuberculosis.

Nahla A. Abdelshafi, Mohamed Fares, Mahmoud Elsabahy, 2021, International journal of pharmaceutics.

Regioselective convergent synthesis of 2-arylidene thiazolo[3,2-a]pyrimidines as potential anti-chikungunya agents

T. Clark, J. Neyts, Muhammad A. Alsherbiny, 2020, RSC advances.

Progress in anion receptor chemistry

Mohamed Fares, Lauren K. Macreadie, Alexander M Gilchrist, 2022, Chem.

Novel Thiazolidinone/Thiazolo[3,2-a]Benzimidazolone-Isatin Conjugates as Apoptotic Anti-proliferative Agents Towards Breast Cancer: One-Pot Synthesis and In Vitro Biological Evaluation

Mohamed Fares, Mohamed El-Naggar, H. Abdel‐Aziz, 2018, Molecules.

Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.

Mohamed Fares, H. Abdel‐Aziz, S. M. Abou-Seri, 2014, European journal of medicinal chemistry.

Synthesis, Biological Evaluation and 2D-QSAR Study of Halophenyl Bis-Hydrazones as Antimicrobial and Antitubercular Agents

Khalid A. Al-Rashood, Hatem A. Abdel-Aziz, Mohamed Fares, 2015, International journal of molecular sciences.

Design, Synthesis and In Vitro Antiproliferative Activity of Novel Isatin‐Quinazoline Hybrids

Mohamed Fares, H. Abdel‐Aziz, Wagdy M. Eldehna, 2015, Archiv der Pharmazie.

An improved synthesis of pyrido[2,3-d]pyrimidin-4(1H)-ones and their antimicrobial activity.

Mohamed Fares, H. Abdel‐Aziz, Wagdy M. Eldehna, 2018, Organic & biomolecular chemistry.

Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.

Ehab S. Taher, Mohamed Fares, K. Orabi, 2019, European journal of medicinal chemistry.

Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects.

C. Supuran, Mohamed Fares, H. Abdel‐Aziz, 2017, Bioorganic & medicinal chemistry.

Advances in fluorescent and colorimetric sensors for anionic species

Philip A. Gale, Mohamed Fares, C. Caltagirone, 2021, Coordination Chemistry Reviews.

Synthesis, X-ray crystallographic analysis, DFT studies and biological evaluation of triazolopyrimidines and 2-anilinopyrimidines

J. Neyts, Muhammad A. Alsherbiny, Mohamed Fares, 2021, Journal of Molecular Structure.

Synthesis, in Vitro and in Silico Studies of Some Novel 5-Nitrofuran-2-yl Hydrazones as Antimicrobial and Antitubercular Agents.

Mohamed Fares, H. Abdel‐Aziz, Wagdy M. Eldehna, 2015, Biological & pharmaceutical bulletin.

Advances in applied supramolecular technologies.

Philip A. Gale, Mohamed Fares, Cally J. E. Haynes, 2021, Chemical Society reviews.

Stimuli-responsive cycloaurated "OFF-ON" switchable anion transporters.

Philip A. Gale, E. Howe, Xin Wu, 2020, Angewandte Chemie.

Reverse engineering Lewy bodies: how far have we come and how far can we go?

H. Lashuel, Mohamed Fares, Somanath Jagannath, 2021, Nature Reviews Neuroscience.

Synthesis, Biological Evaluation and Molecular Docking of Certain Sulfones as Potential Nonazole Antifungal Agents

Muhammad A. Alsherbiny, Mohamed Fares, H. Abdel‐Aziz, 2016, Molecules.

Anti-Inflammatory and Cytostatic Activities of a Parthenolide-Like Sesquiterpene Lactone from Cota palaestina subsp. syriaca

N. Saliba, Mohamed Fares, S. Talhouk, 2015, Evidence-based complementary and alternative medicine : eCAM.

Toward the Identification of Potential α-Ketoamide Covalent Inhibitors for SARS-CoV-2 Main Protease: Fragment-Based Drug Design and MM-PBSA Calculations

Mohamed Fares, H. Alkahtani, Wagdy M. Eldehna, 2021, Processes.

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication

R. Bartenschlager, P. Chlanda, S. Boulant, 2021, bioRxiv.

Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of β-catenin/connexin43 association.

M. El-Sabban, Mohamed Fares, H. Hariri, 2013, Experimental cell research.

N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting

H. Lashuel, A. Chiki, Mohamed Fares, 2018, The Journal of Biological Chemistry.

Insilico Codon Bias Correction for Transgenic Biological Protein Sequences for Vaccine Production

Mohamed Fares, Mohamed El-Hadidi, Mohamed Abuelanin, 2020, 2020 2nd Novel Intelligent and Leading Emerging Sciences Conference (NILES).

Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors.

C. Supuran, Mohamed Fares, H. Abdel‐Aziz, 2022, European journal of medicinal chemistry.

Discovery of potent dual-tailed benzenesulfonamide inhibitors of human carbonic anhydrases im-plicated in glaucoma and in vivo profiling of their intraocular pressure lowering action.

C. Supuran, E. Masini, T. Peat, 2020, Journal of medicinal chemistry.

Adipocyte of Obese Breast Cancer Patients Is Characterized by The Overexpression of Caveolin-1 Protein/Mediator the Main Constituent of the Plasma Membrane Vesicles Caveolae That Contain Proteins Contribute to Breast Cancer Progression

Mohamed Fares, H. Mohamed, M. El-Shinawi, 2020 .

Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.

C. Supuran, Mohamed Fares, H. Abdel‐Aziz, 2017, European journal of medicinal chemistry.

Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.

S. Zada, Mohamed Fares, Mamdouh M. Ali, 2015, European journal of medicinal chemistry.

Breast cancer subtypes criteria versus clinicopathological data

Mohamed Fares, M. El-Shinawi, S. Ibrahim, 2019 .

Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease

E. Masliah, H. Lashuel, E. Rockenstein, 2016, Proceedings of the National Academy of Sciences.

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

A. Gitler, J. Holton, H. Lashuel, 2014, Human molecular genetics.

Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells

H. Lashuel, D. Eliezer, Mohamed Fares, 2012, The Journal of Biological Chemistry.

Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties

Hazem A. Ghabbour, Hatem A. Abdel-Aziz, Mohamed Fares, 2016, Molecules.

A Facile Synthesis of Pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidine and Pyrido[2′,3′:3,4]pyrazolo[5,1-c][1,2,4]triazine Bearing a Thiophene Moiety

K. Dawood, Mohamed Fares, H. Abdel‐Aziz, 2013 .

A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death.

Xin Wu, Mohamed Fares, R. Pérez-Tomás, 2023, Organic & biomolecular chemistry.

Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo*

E. Masliah, H. Lashuel, S. Tenreiro, 2015, The Journal of Biological Chemistry.

Predictive models of RNA degradation through dual crowdsourcing

Michele Tinti, Youhan Lee, Andrew M. Watkins, 2021, ArXiv.

Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo*

E. Masliah, H. Lashuel, S. Tenreiro, 2015, The Journal of Biological Chemistry.

Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer.

Tamer M. Ibrahim, C. Supuran, F. Şahin, 2023, European journal of medicinal chemistry.

Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects.

C. Supuran, Mohamed Fares, H. Abdel‐Aziz, 2017, Bioorganic & medicinal chemistry.